PySAHA is a versatile HDAC inhibitor that degrades intracellular HDAC through a hydrophobic tagging mechanism. It also exhibits photodynamic therapeutic activity, generating reactive oxygen species upon light exposure. PySAHA inhibits breast cancer cell proliferation and migration while inducing apoptosis (apoptosis). The compound has antitumor properties valuable for breast cancer research.
Target:
Apoptosis|||HDAC|||ROS
* VAT and and shipping costs not included. Errors and price changes excepted
